TVTX logo

Travere Therapeutics (TVTX) Net Margin

Annual Net Margin

-137.90%
-61.20%-79.79%

December 31, 2024


Summary


Performance

TVTX Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Quarterly Net Margin

-80.58%
+6.56%+7.53%

December 1, 2024


Summary


Performance

TVTX Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

TVTX Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-79.8%+59.7%
3 y3 years-0.9%+59.7%
5 y5 years-65.1%+59.7%

TVTX Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.8%+45.8%at high+75.5%
5 y5-year-79.8%+45.8%-4868.1%+75.5%
alltimeall time-284.6%+64.9%-308.4%+100.0%

Travere Therapeutics Net Margin History

DateAnnualQuarterly
Dec 2024
-137.90%(+79.8%)
-
Dec 2024
-
-80.58%(-7.5%)
Sep 2024
-
-87.14%(-33.0%)
Jun 2024
-
-130.11%(-60.4%)
Mar 2024
-
-328.86%(+64.3%)
Dec 2023
-76.70%(-69.9%)
-200.12%(-24.8%)
Jun 2023
-
-265.96%(-4.8%)
Mar 2023
-
-279.50%(+24.6%)
Dec 2022
-254.41%(+86.2%)
-224.35%(-9.6%)
Sep 2022
-
-248.11%(+100.5%)
Jun 2022
-
-123.75%(-21.0%)
Mar 2022
-
-156.68%(+199.9%)
Dec 2021
-136.60%(+59.9%)
-
Sep 2021
-
-52.24%(-26.9%)
Jun 2021
-
-71.43%(-37.1%)
Mar 2021
-
-113.63%(-52.4%)
Dec 2020
-85.43%(+2.3%)
-238.55%(+441.1%)
Sep 2020
-
-44.09%(-18.1%)
Jun 2020
-
-53.83%(-3285.2%)
Mar 2020
-
1.69%(-102.6%)
DateAnnualQuarterly
Dec 2019
-83.51%(+33.6%)
-64.81%(-21.2%)
Sep 2019
-
-82.23%(-5.0%)
Jun 2019
-
-86.57%(-16.4%)
Mar 2019
-
-103.56%(+508.1%)
Dec 2018
-62.51%(+62.2%)
-17.03%(-87.3%)
Sep 2018
-
-133.93%(+147.9%)
Jun 2018
-
-54.02%(+13.0%)
Mar 2018
-
-47.82%(+14.5%)
Dec 2017
-38.55%(+7.5%)
-41.77%(-5.3%)
Sep 2017
-
-44.11%(+29.4%)
Jun 2017
-
-34.10%(+3.4%)
Mar 2017
-
-32.99%(+43.1%)
Dec 2016
-35.86%(-90.9%)
-23.05%(-78.9%)
Sep 2016
-
-109.33%(+171.7%)
Jun 2016
-
-40.24%(-204.1%)
Mar 2016
-
38.67%(-576.8%)
Dec 2015
-
-8.11%(-92.4%)
Jun 2015
-
-106.06%(-48.5%)
Dec 2014
-393.36%
-206.08%(-4.3%)
Sep 2014
-
-215.36%(-99.9%)
Mar 2014
-
-271.45 K%

FAQ

  • What is Travere Therapeutics annual net profit margin?
  • What is the all time high annual net margin for Travere Therapeutics?
  • What is Travere Therapeutics annual net margin year-on-year change?
  • What is Travere Therapeutics quarterly net profit margin?
  • What is the all time high quarterly net margin for Travere Therapeutics?
  • What is Travere Therapeutics quarterly net margin year-on-year change?

What is Travere Therapeutics annual net profit margin?

The current annual net margin of TVTX is -137.90%

What is the all time high annual net margin for Travere Therapeutics?

Travere Therapeutics all-time high annual net profit margin is -35.86%

What is Travere Therapeutics annual net margin year-on-year change?

Over the past year, TVTX annual net profit margin has changed by -61.20% (-79.79%)

What is Travere Therapeutics quarterly net profit margin?

The current quarterly net margin of TVTX is -80.58%

What is the all time high quarterly net margin for Travere Therapeutics?

Travere Therapeutics all-time high quarterly net profit margin is 38.67%

What is Travere Therapeutics quarterly net margin year-on-year change?

Over the past year, TVTX quarterly net profit margin has changed by +119.54% (+59.73%)